Vivani Medical Inc (VANI)

May 20, 2025, 5:47 AM EDT - 16 days ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR CLPT EDIT NTLA VERV

May 13, 2025, 4:30 PM EDT - 23 days ago

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 7, 2025, 8:30 AM EDT - 4 weeks ago

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

Apr 15, 2025, 8:30 AM EDT - 7 weeks ago

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Mar 31, 2025, 7:30 AM EDT - 2 months ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025, 7:32 AM EDT - 2 months ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Mar 26, 2025, 7:30 AM EDT - 2 months ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Mar 24, 2025, 8:30 AM EDT - 2 months ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Mar 13, 2025, 7:30 AM EDT - 3 months ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Mar 12, 2025, 8:30 AM EDT - 3 months ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Mar 12, 2025, 8:00 AM EDT - 3 months ago

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

CRGT

Dec 19, 2024, 8:30 AM EST - 6 months ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 4, 2024, 8:30 AM EST - 6 months ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Nov 13, 2024, 8:30 AM EST - 7 months ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Oct 22, 2024, 8:30 AM EDT - 8 months ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Sep 26, 2024, 8:30 AM EDT - 9 months ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 23, 2024, 8:57 AM EDT - 9 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 4, 2024, 8:00 AM EDT - 9 months ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Aug 28, 2024, 7:10 PM EDT - 10 months ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 4:05 PM EDT - 10 months ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 8:00 AM EDT - 11 months ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

May 28, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 13, 2024, 4:45 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 6, 2024, 8:00 AM EST - 1 year ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 1, 2024, 7:49 AM EST - 1 year ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Feb 29, 2024, 7:25 AM EST - 1 year ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 28, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Nov 14, 2023, 6:00 AM EST - 1 year ago

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Oct 16, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical to Present at BIO Investor Forum

Sep 7, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical to Present at the Boulder Peptide Symposium

Sep 5, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Aug 14, 2023, 5:45 PM EDT - 1 year ago

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Jul 11, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Jun 14, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

May 15, 2023, 6:15 AM EDT - 2 years ago

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

Apr 4, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Mar 31, 2023, 2:50 PM EDT - 2 years ago

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Mar 21, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Nov 14, 2022, 4:46 PM EST - 2 years ago

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Oct 17, 2022, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the ThinkEquity Investor Conference

Aug 31, 2022, 6:00 AM EDT - 3 years ago

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)